Table 5

Distribution in CAD-free and CAD groups, FVIII:c levels, and lipid levels according to LRP1 −25C/G polymorphism (data available for 963 subjects)

CAD-free (n = 280), %CAD (n = 683), %PFVIII:c, IU/dLPTotal cholesterol, mMPLDL cholesterol, mMPHDL cholesterol, mMPTotal cholesterol/HDL ratioPTriglycerides, mMP
LRP1 −25C/G                
    CC (n = 773) 83.2 79.1  165 ± 53  5.71 ± 1.13  3.79 ± 0.99  1.28 ± 0.36  4.80 ± 1.52  1.85 ± 1.13  
    CG (n = 174) 16.1 18.9 .180* 163 ± 52 .295 5.60 ± 1.06 .038 3.70 ± 0.95 .049 1.25 ± 0.33 .577 4.80 ± 1.81 .495 1.76 ± 0.80 .555 
    GG (n = 16) 0.7 2.0  185 ± 65  5.05 ± 0.61  3.16 ± 0.52  1.25 ± 0.33  4.28 ± 1.11  1.67 ± 0.53  
    Carrrier G (vs CC) 16.8 20.9 .142* 165 ± 53 .981 5.55 ± 1.04 .079 3.66 ± 0.93 .121 1.25 ± 0.33 .294 4.75 ± 1.76 .756 1.75 ± 0.78 .299 
    Carrrier C (vs GG) 99.3 98.0 .141* 165 ± 53 .130 5.69 ± 1.12 .024 3.77 ± 0.98 .025 1.27 ± 0.35 .797 4.80 ± 1.58 .235 1.83 ± 1.08 .566 
CAD-free (n = 280), %CAD (n = 683), %PFVIII:c, IU/dLPTotal cholesterol, mMPLDL cholesterol, mMPHDL cholesterol, mMPTotal cholesterol/HDL ratioPTriglycerides, mMP
LRP1 −25C/G                
    CC (n = 773) 83.2 79.1  165 ± 53  5.71 ± 1.13  3.79 ± 0.99  1.28 ± 0.36  4.80 ± 1.52  1.85 ± 1.13  
    CG (n = 174) 16.1 18.9 .180* 163 ± 52 .295 5.60 ± 1.06 .038 3.70 ± 0.95 .049 1.25 ± 0.33 .577 4.80 ± 1.81 .495 1.76 ± 0.80 .555 
    GG (n = 16) 0.7 2.0  185 ± 65  5.05 ± 0.61  3.16 ± 0.52  1.25 ± 0.33  4.28 ± 1.11  1.67 ± 0.53  
    Carrrier G (vs CC) 16.8 20.9 .142* 165 ± 53 .981 5.55 ± 1.04 .079 3.66 ± 0.93 .121 1.25 ± 0.33 .294 4.75 ± 1.76 .756 1.75 ± 0.78 .299 
    Carrrier C (vs GG) 99.3 98.0 .141* 165 ± 53 .130 5.69 ± 1.12 .024 3.77 ± 0.98 .025 1.27 ± 0.35 .797 4.80 ± 1.58 .235 1.83 ± 1.08 .566 
*

By χ2 test.

By analysis of variance.

By t test.

Close Modal

or Create an Account

Close Modal
Close Modal